1921
Volume 23, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

A clinical trial comparing the efficacy and toxicity of WR 33063, a phenanthrenemethanol derivative, and quinine sulfate, was undertaken in adult Thai males with infections hospitalized in Prachinburi, Thailand. A 6-day course of WR 33063, 1.8 g daily, in divided doses, cured 23 of 25 patients. Quinine sulfate, in a course of 1.95 g daily in divided doses for 6 days, cured 21 of 22 patients. WR 33063 treatment was accompanied by a smaller number of side effects than treatment with quinine sulfate. Hematologic and biochemical abnormalities were not detected during or following treatment with either drug. An extended trial of WR 33063 and WR 30090, a quinolinemethanol derivative, is in progress.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1974.23.560
1974-07-01
2017-11-21
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1974.23.560
Loading
  • Accepted : 01 Dec 1973

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error